TELA Bio Inc.

NASDAQ: TELA · Real-Time Price · USD
1.58
-0.02 (-1.25%)
At close: Aug 15, 2025, 3:59 PM
1.58
-0.05%
After-hours: Aug 15, 2025, 04:04 PM EDT

TELA Bio Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
75.32M 71.22M 69.3M 68.65M 64.74M 63.15M 58.45M 53.08M 49.18M 45.1M 41.42M 38.17M 34.66M 31.82M 29.46M 26.76M 24.41M 20.36M
Cost of Revenue
24.63M 23.55M 22.81M 21.76M 20.32M 19.6M 18.34M 16.41M 15.59M 15.15M 14.37M 13.64M 12.86M 11.47M 10.65M 9.94M 8.91M 7.87M
Gross Profit
50.7M 47.66M 46.49M 46.89M 44.42M 43.55M 40.11M 36.66M 33.59M 29.94M 27.04M 24.53M 21.81M 20.35M 18.81M 16.82M 15.5M 12.5M
Operating Income
-37.27M -39.76M -41.69M -45.62M -46.44M -45.23M -44.08M -41.24M -40.54M -40.42M -39.01M -37.22M -34.95M -32.03M -29.45M -28.54M -28.19M -26.05M
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-40.83M -43.54M -37.98M -41.52M -42.11M -40.3M -46.66M -43.75M -43.51M -45.46M -44.3M -42.94M -40.49M -36M -33.28M -32.45M -31.88M -29.71M
Net Income
-40.77M -43.44M -37.84M -41.52M -42.11M -40.3M -48.68M -45.56M -46.55M -49.11M -46.94M -45.79M -42.11M -37.02M -33.28M -32.45M -31.88M -29.71M
Selling & General & Admin
79.13M 78.47M 79.37M 83.04M 81.09M 78.82M 74.57M 68.24M 64.74M 61.38M 57.11M 53.81M 49.52M 45.3M 41.52M 39.18M 37.72M 33.52M
Research & Development
8.84M 8.96M 8.81M 9.47M 9.77M 9.96M 9.62M 9.66M 9.39M 8.98M 8.94M 7.94M 7.24M 7.07M 6.74M 6.18M 5.97M 5.02M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -107K -150K -150K -230K -101K -58K n/a 49K
Operating Expenses
87.97M 87.42M 88.18M 92.51M 90.86M 88.78M 84.19M 77.9M 74.14M 70.36M 66.05M 61.75M 56.76M 52.37M 48.26M 45.36M 43.69M 38.54M
Interest Expense
2.66M 5.18M 5.29M 5.35M 5.34M 5.31M 5.22M 5.05M 4.75M 4.39M 4.05M 3.8M 3.69M 3.62M 3.6M 3.58M 3.55M 3.57M
Selling & Marketing Expenses
63.89M 63.74M 64.65M 67.86M 65.86M 63.73M 59.68M 54.16M 50.86M 47.34M 43.25M 39.92M 35.69M 32.14M 29.06M 27.13M 26.52M 23.14M
Cost & Expenses
112.59M 110.98M 103.42M 106.69M 103.6M 100.79M 102.53M 94.31M 89.73M 85.51M 80.42M 75.39M 69.62M 63.84M 58.91M 55.3M 52.6M 46.41M
Income Tax Expense
-125K -92K -144K n/a n/a n/a 2.02M 1.81M 3.04M 3.65M 2.65M 2.85M 1.63M 1.02M n/a n/a n/a n/a
Shares Outstanding (Basic)
45.37M 45.27M 40.07M 24.7M 24.66M 24.58M 24.49M 24.48M 23.24M 19.19M 19.16M 16.76M 14.56M 14.48M 14.51M 14.49M 14.46M 14.44M
Shares Outstanding (Diluted)
45.37M 45.27M 40.07M 24.7M 24.66M 24.58M 24.49M 24.48M 23.24M 19.19M 19.16M 16.76M 14.56M 14.54M 14.51M 14.49M 14.46M 14.44M
EPS (Basic)
-1.12 -1.41 -1.39 -1.69 -1.72 -1.67 -2.17 -2.15 -2.41 -2.87 -2.96 -3.04 -2.9 -2.55 -2.29 -2.24 -2.2 -2.16
EPS (Diluted)
-1.12 -1.41 -1.39 -1.69 -1.72 -1.67 -2.17 -2.15 -2.41 -2.87 -2.96 -3.04 -2.9 -2.55 -2.29 -2.24 -2.2 -2.16
EBITDA
-35.38M -37.31M -31.68M -35.26M -35.9M -34.16M -40.63M -37.85M -37.92M -39.83M -39.06M -38.02M -35.76M -31.83M -29.14M -28.33M -27.78M -25.6M
EBIT
-27.09M -38.36M -32.7M -36.17M -36.77M -34.99M -41.44M -38.7M -38.76M -41.08M -40.24M -39.14M -36.8M -32.38M -29.68M -28.87M -28.33M -26.14M
Depreciation & Amortization
796K 1.04M 1.01M 907K 862K 827K 808K 854K 841K 1.25M 1.19M 1.12M 1.04M 549K 535K 537K 549K 533K